Zimmer Biomet · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← ZBH

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-30	2.18	+4.8%	70.8%	0.33	0.20	9.1%	0.39	1.03	0.25	0.05
FY2026 Q1	2026-03-31	2.09	+9.3%	72.4%	0.37	0.24	11.4%	0.32	1.22	0.25	0.05
FY2025 Q4	2025-12-31	2.24	+10.9%	64.7%	0.15	0.14	6.2%	0.44	0.71	0.25	0.05
FY2025 Q3	2025-09-30	2.00	+9.7%	72.1%	0.35	0.23	11.5%	0.36	1.16	0.00	0.05
FY2025 Q2	2025-06-30	2.08	+7.0%	71.5%	0.30	0.15	7.4%	0.33	0.77	0.01	0.05
FY2025 Q1	2025-03-31	1.91	+1.1%	71.2%	0.29	0.18	9.5%	0.34	0.91	0.23	0.05
FY2024 Q4	2024-12-31	2.02	+4.3%	71.0%	0.39	0.24	11.8%	0.45	1.18	0.07	0.05
FY2024 Q3	2024-09-30	1.82	+4.0%	70.5%	0.28	0.25	13.7%	0.35	1.23	0.60	0.05
FY2024 Q2	2024-06-30	1.94	+3.9%	71.5%	0.35	0.24	12.5%	0.32	1.18	0.09	0.05
FY2024 Q1	2024-03-31	1.89	+3.2%	72.9%	0.27	0.17	9.1%	0.17	0.84	0.11	0.05
FY2023 Q4	2023-12-31	1.94	+6.3%	72.2%	0.35	0.42	21.6%	0.53	2.00	0.41	0.05
FY2023 Q3	2023-09-30	1.75	+5.0%	70.4%	0.27	0.16	9.3%	0.25	0.77	0.00	0.05
FY2023 Q2	2023-06-30	1.87	—	71.9%	0.33	0.21	11.2%	0.25	1.00	0.01	0.05
FY2023 Q1	2023-03-31	1.83	—	72.6%	0.33	0.23	12.7%	0.26	1.11	0.27	0.05
FY2022 Q4	2022-12-31	1.83	—	71.5%	-0.03	-0.13	-7.2%	—	-0.62	—	0.05
FY2022 Q3	2022-09-30	1.67	—	70.8%	0.25	0.19	11.6%	—	0.92	—	0.05

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.